Antibody-mediated DENV2 infection inhibition assay. Vero cells were either treated with various concentrations of rabbit polyclonal anti-annexin II antibody, 20 µg of rabbit polyclonal anti-histag antibody or no antibody (control), for 1 h, prior to DENV2 adsorption. Infections were allowed for 30 h. (A) Intracellular DENV2 titer was quantified with Liferiver DENV general-type real time RT-PCR Kit. (B) Extracellular DENV2 titer was determined by TCID50. The experiment was independently repeated in triplicates. Statistically significant reduction in virus infection and output were observed in the anti-annexin-II-treated Vero cells, compared to the control-antibody-treated and no-antibody-treated Vero cells (** indicates p < 0.01, **** indicates p < 0.0001), as determined by one-way ANOVA analysis; ab—antibody.